Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
Many people with type 2 diabetes cannot maintain target blood glucose levels when taking a
single oral drug. The purpose of this study is to assess the safety and effectiveness of the
combination of vildagliptin, an unapproved drug, and pioglitazone in lowering overall blood
glucose levels in people with type 2 diabetes who have not previously been treated with drug
therapy to lower their blood sugar.